UPDATE: GeneFormatics Expands Capabilities Through NMR Acquisition; New Partnership Deal Expected | GenomeWeb

This story has been updated from a previous version.

NEW YORK, Jan 17 – GeneFormatics’ acquisition of Structure Function Genomics, a Princeton, NJ-based developer of tools to speed up nuclear magnetic resonance spectroscopy, is part of the company’s strategy to gain access to all three leading proteomics technologies, GeneFormatics CEO and president said Wednesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.